NSTEMI 0,7005 ng/ml (SD ± 0,49) ng/ml and STEMI patients 0,378 ng/ml (IQR 0,055–0,0701) had fairly similar TLR2-plasma levels, all in all not statistically significant amongst themselves and when compared to non-CAD levels of TLR2 plasma levels (p = 0,1946; p = >0,9999; p = 0,1230). The gene discussed is TLR2; the disease is coronary artery disorder.